Best Red Flags to Watch for When Buying Peptides Online
Ten warning signs of an unsafe peptide seller, from research use only labels to unverifiable pharmacies, drawn from FDA guidance and published lab testing.
ACT 2 Health Clinical Team · Updated September 23, 2026
Peptides are sold online through two very different channels. One is the prescription route: a licensed clinician evaluates you, and a licensed pharmacy dispenses a medication, often a compounded one. The other is a gray market of websites selling vials labeled for research, with no clinician and no pharmacy in between. The two can look similar on a phone screen. These ten warning signs, drawn from FDA guidance and published laboratory testing, help you tell them apart. None of this is advice to use any peptide; it is a guide to spotting sellers to avoid.
1. "Research use only" or "not for human consumption" on the label
What it is: a vial or product page that says the contents are for laboratory research, while the site is plainly selling to individuals.
Why it matters: FDA has warned companies that sold unapproved drugs falsely labeled "for research purposes" or "not for human consumption" directly to consumers for human use, and it urges consumers not to buy them because they are of unknown quality and may be harmful (FDA). Testing backs this up. When Belgian researchers analyzed peptide drugs bought from suspected illegal internet pharmacies, purity ranged from 5% to 75% for one group of peptides, and several samples contained arsenic or lead (Janvier et al., 2018).
Practical note: the label means what it says. It is not a loophole, and it is not a sign of higher quality.
2. No prescription and no clinician screening
What it is: checkout without any medical questions, or a questionnaire nobody appears to read.
Why it matters: FDA lists "does not require a screening and prescription by a licensed doctor" as a warning sign (FDA). Screening matters more with age because the list of other medications grows: in US data, 14.5% of adults aged 40 to 59 and 34.5% of adults aged 60 to 79 had used five or more prescription drugs in the past 30 days (CDC NCHS). Someone needs to look at that list.
Practical note: expect to be asked about your conditions, your current medications and your goals, and expect that the answer can be no.
3. A pharmacy you cannot verify
What it is: no pharmacy named at all, a name you cannot find, or a seller that ships from somewhere it will not disclose.
Why it matters: FDA advises checking any online pharmacy in your state board of pharmacy's license database and says that if it is not listed, you should not use it. If it is listed, FDA says to confirm it requires a prescription, gives a US physical address and phone number, and has a licensed pharmacist available (FDA). FDA has also seen fraudulent compounded products whose labels name pharmacies that do not exist, or real pharmacies that did not make the product (FDA).
Practical note: ask the provider which pharmacy fills the prescription, then look it up yourself rather than trusting a badge on the website.
4. Silence about compounding, or no answer to "503A or 503B?"
What it is: a product described as "pharmaceutical grade" or "clinic quality" with no statement of whether it is FDA-approved or compounded.
Why it matters: compounded medications are not FDA-approved and are not reviewed by the FDA for safety or effectiveness. State boards of pharmacy oversee most compounding pharmacies, while 503B outsourcing facilities register with FDA, are inspected on a risk-based schedule and must meet current good manufacturing practice requirements (FDA). FDA publishes the list of registered outsourcing facilities.
Practical note: a legitimate provider will tell you whether a medication is compounded, and by which type of facility, without being pressed. Our explainer on what compounded means covers the questions to ask.
5. "Same as Ozempic" or "generic" claims
What it is: marketing that calls a compounded or unbranded product identical to, or a generic of, a branded drug.
Why it matters: FDA lists claims that "the compounded drug is the same as an FDA-approved drug" as a red flag (FDA). Compounded medications are not equivalent to or interchangeable with any branded product, and clinical trial results for the branded drug do not apply to them.
Practical note: treat any equivalence claim as a reason to leave the site.
6. Promises that a peptide will heal, fix or reverse something
What it is: product pages promising faster healing, reversed aging or certain results.
Why it matters: human evidence for many popular peptides is limited and early. A 2026 review in Missouri Medicine notes that unapproved peptides such as BPC-157, TB-500 and melanotan-II lack established human safety profiles (Moiz et al., 2026). FDA's page on bulk substances that may present significant safety risks, content current as of April 22, 2026, says of BPC-157, DSIP, epitalon, MOTS-c and TB-500 that the agency lacks sufficient information to know whether they would cause harm in humans (FDA). An FDA advisory committee discussed several of these peptides in July 2026; FDA notes such committees make non-binding recommendations (FDA).
Practical note: a careful provider tells you where the evidence is thin. Certainty is a warning sign.
7. Investigational drugs that are not approved anywhere
What it is: sites selling experimental compounds, such as retatrutide, that are still in clinical trials.
Why it matters: FDA states that retatrutide and cagrilintide cannot be used in compounding under federal law and have not been found safe and effective for any condition, and it has warned telehealth companies for marketing retatrutide (FDA).
Practical note: if a drug's only public data comes from ongoing trials, no legitimate pharmacy should be selling it to you.
8. Prices that seem too good to be true
What it is: vials at a fraction of what licensed providers charge, often with bulk discounts.
Why it matters: FDA lists deep discounts and "prices that seem too good to be true" among its red flags (FDA). In one test-purchase study, semaglutide vials bought online without a prescription at the lowest prices measured 7.7% to 14.37% purity against a 99% label claim, endotoxin was found in every sample, and none of the ordered prefilled pens arrived (Ashraf et al., 2024).
Practical note: compare total cost with licensed providers that publish their prices. A large gap usually has an explanation you will not like.
9. Packaging and labels that do not look right
What it is: misspellings, a pharmacy address that does not match, missing instructions, damaged packaging, or a product that looks different from last time.
Why it matters: FDA lists all of these as warning signs, and advises against using injectable GLP-1 products that arrive warm or without adequate cold packs (FDA).
Practical note: photograph anything unusual before you contact the provider, and do not use the product until someone qualified has answered.
10. Nobody to call after the sale
What it is: no clinician follow-up, no pharmacist contact and no way to report a problem.
Why it matters: FDA flags sellers that do not have a licensed doctor available to answer questions after you receive your medication (FDA). Side effects and product problems can be reported to FDA through MedWatch.
Practical note: before you pay, find out who you would contact about a reaction, and how quickly they respond.
A note for competitive athletes
If you still compete, including masters or age-group events, the prescription route does not settle the anti-doping question. USADA explains that BPC-157 is prohibited under the WADA list in the S0 Non-Approved Substances category and is not approved for human clinical use in the US (USADA). Check before you start anything.
Where this fits
Avoiding bad sellers is the first step; choosing a good provider is the second. For the regulatory background, see are peptides legal?, and for the safety picture, are peptides safe?. A clinician can review your history and current medications and tell you whether a peptide makes sense at all, and when it does not.
Our comparison of peptide therapy clinics sets out how six providers handle clinician visits, labs, pricing and compounded status.
Sources
- https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
- https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy
- https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
- https://www.fda.gov/drugs/human-drug-compounding/registered-outsourcing-facilities
- https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks
- https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026
- https://pubmed.ncbi.nlm.nih.gov/30029448/
- https://pubmed.ncbi.nlm.nih.gov/39509151/
- https://pubmed.ncbi.nlm.nih.gov/42757290/
- https://www.cdc.gov/nchs/products/databriefs/db347.htm
- https://www.usada.org/spirit-of-sport/bpc-157-peptide-prohibited/
- https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program
Frequently asked questions
Products labeled for research use only are not approved for human use. FDA has warned companies that sold unapproved drugs falsely labeled for research purposes or not for human consumption while marketing them to consumers, and it urges consumers not to buy them because they are of unknown quality. A prescription from a licensed clinician, filled by a licensed pharmacy, is the lawful route.
Look the pharmacy up in your state board of pharmacy's license database; FDA links to each state's database. FDA says that if the pharmacy is not listed, you should not use it. If it is listed, confirm that it requires a prescription, gives a US physical address and phone number, and has a licensed pharmacist available to answer questions.
No. Compounded medications are prepared by a licensed pharmacy for a patient with a prescription. They are not FDA-approved and are not reviewed by the FDA for safety or effectiveness, but pharmacies are overseen by state boards or, for 503B outsourcing facilities, by FDA. Research use only products sit outside that system entirely.
Seek medical care for any serious symptoms, and tell your clinician exactly what you took, including the label. You can also report the problem to FDA through MedWatch, its safety information and adverse event reporting program. Keep the vial, packaging and any receipts, since they may help identify the product.
Many are. USADA explains that BPC-157 is prohibited under the World Anti-Doping Agency list in the S0 Non-Approved Substances category. If you compete in tested events, including masters and age-group competition, check the current prohibited list before taking any peptide, prescribed or not.
This page is educational and is not medical advice. Treatments are available only to eligible patients following clinical evaluation. How we write and review our content.